Citron Research Founder and Executive Editor Andrew Left says now is the time to buy Snap because the stock is so beaten down.
The chip space and Nvidia in particular have been hit hard this month, but JPMorgan believes the company's about to turn a corner.
Citi upgrades the stock to buy, noting that investors should take advantage of recent weakness to buy the stock. Strength of management and a robust turnaround plan will drive future gains.
Barclays initiates coverage on medical technology names with a positive view. Top picks include Abbott Labs, Boston Scientific, Stryker, and Medtronic.
Walmart upgraded to buy at Deutsche Bank
Health care gained 14.04% in the third quarter, but traders say individual names within the space are under valued and poised to move higher.
As Under Armour updates the Street on its restructuring plan, investors and analysts are split on whether the company can deliver.
D. A. Davidson is bullish on shares of Estée Lauder, but some traders believe there are better bets in the beauty space.
Roku popped more than 20% after beating revenue estimates for Q2. HPM Partners' Jim Lebenthal owns the stock and believes there's more upside ahead as the company continues to grow its services business.